GlucoTrack, Inc. (NasdaqCM: GCTK)
Health Care · Health Care Equipment & Supplies · US
$0.35
-5.44% today · -92.9% 1Y
GlucoTrack, Inc. (NasdaqCM: GCTK) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $2.17M and employs 15 people.
Over the last twelve months the share price has lost 92.9%, trading between 0.25 and 14.14.
Tweenvest scores GlucoTrack, Inc. across four factors: quality 13/100. Its strongest factor is quality.
GCTK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.17M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -7.52
- Dividend yield
- —
- Beta (5Y)
- 0.66
- 52-week high
- $14.14
- 52-week low
- $0.25
- Avg volume (3M)
- —
- Shares outstanding
- 6.26M
- Employees
- 15
- Next earnings
- —
About GlucoTrack, Inc.
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
- ISIN
- US45824Q8042
- Founded
- 2001
- Listed since
- Apr 25, 2013
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.